<DOC>
	<DOCNO>NCT01177865</DOCNO>
	<brief_summary>RATIONALE : Gathering information patient prostate cancer may help doctor learn patient choose treatment option . PURPOSE : This study look treatment choice patient localized prostate cancer .</brief_summary>
	<brief_title>Study Treatment Choice Patients With Localized Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To evaluate importance prostate cancer treatment characteristic men localize prostate cancer . - To determine extent men choose strengths weaknesses one treatment different set strengths weakness another treatment making choice . Secondary - To determine correlation attribute important men baseline demographic , functional status , disease risk characteristic . OUTLINE : This multicenter study . Patients complete 'discrete choice experiment ' questionnaire presenting three treatment option base 8 aspect treatment . Attributes relevant men prostate cancer ( e.g. , sexual health , urinary function , return normal activity [ work , gardening , sport , shop ] ) apply surveillance , radical therapy new minimally-invasive therapy select consideration . Baseline demographic age , working/retired/unemployed/household income , prostate cancer characteristic ( PSA level , Gleason grade , stage ) , baseline functional status ( genitourinary function ) , final treatment choice also collect order ascertain whether relationship association patient preference treatment baseline demographic . Individuals ask choose three treatment profile .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histological diagnosis adenocarcinoma prostate transrectal transperineal template prostate biopsy Clinical stage ≤ T2c N0 M0 ( radiological T3a allow ) Local stag image per guideline demonstrate localize disease ( e.g. , MRI , CT , and/or bone scan ) No metastatic disease nodal disease outside prostate bone scan crosssectional imaging No prior prostate surgery cancer control ( e.g. , radical prostatectomy , highintensity focus ultrasound ablation , cryosurgery , photodynamic therapy ) treatment prostate cancer Gleason grade ≤ 7 Serum PSA ≤ 15 ng/mL PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior radiotherapy No androgen suppression/hormone treatment within previous 12 month prostate cancer</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
</DOC>